Ephedra Ban Court Challenge Could Be Good News For FDA, Win Or Lose
This article was originally published in The Tan Sheet
FDA's decision to ban ephedra outright creates a win-win situation for the agency, regardless of whether the regulation stands up in court
You may also be interested in...
A 1final rule prohibiting the sale of dietary supplements containing ephedrine alkaloids will become effective April 12, FDA announced Feb. 6
A House version of the Dietary Supplement Health & Education Act "Full Implementation" Senate bill is expected early this year, marking the impact of industry efforts to respond to a challenging year in Washington
FDA's regulatory framework for removing dangerous dietary supplements from the market under the Dietary Supplement Health & Education Act's "unreasonable risk" standard will be issued shortly by the agency